Frost & Sullivan Presents 2004 Product Line Innovation Award to Bruker Daltonics

BILLERICA, Mass.--()--May 10, 2004--Bruker BioSciences Corporation (NASDAQ: BRKR) today announces that Frost & Sullivan has selected the Company's Bruker Daltonics subsidiary for their 2004 Product Line Innovation Award for the Life Sciences.

Frost & Sullivan analyst Sinead Igoe stated: "Bruker Daltonics has received this award for its innovative development of sophisticated mass spectrometers. Concentrating on meeting the needs of life science researchers, Bruker Daltonics aids the researchers in overcoming complex challenges encountered in their life science research, especially in the proteomics field. Bruker Daltonics offers innovative, high quality solutions that support all life science applications from genomics through to clinical proteomics. Bruker Daltonics offers a suite of sophisticated mass spectrometers providing researchers the option of various solutions from a trusted manufacturer."

Frost & Sullivan manager Manoj Kenkare added: "Bruker Daltonics recognizes the changing needs of researchers involved in the life science market and responds with enhanced capabilities. Experiencing great adoption and acceptance of its life science mass spectrometers, the company continues to enjoy revenue growth, demonstrated by a 29% increase in revenues in 2003 over 2002. A leader in the life science mass spectrometry space, Bruker Daltonics is positioned to continue growth and success. Bruker Daltonics focuses on providing highly innovative and advanced solutions to the life science researchers to generate the highest quality and information-rich analyses. This aim of meeting researchers' needs and providing innovative, top-of-the-line solutions to create highly sophisticated product lines warrants Bruker Daltonics' receiving Frost & Sullivan's 2004 Product Line Innovation Award."

Frank Laukien, Ph.D., President and CEO of Bruker Daltonics, commented: "We are very gratified by this award, and pleased to have been recognized by Frost & Sullivan for the fourth time in three years for our innovation and growth strategy in the life sciences."

ABOUT BRUKER BIOSCIENCES

Bruker BioSciences, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. For more information about Bruker BioSciences Corporation, please visit www.bruker-biosciences.com.

CAUTIONARY STATEMENT

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2003, our most recent quarterly reports on Form 10-Q, and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.

Contacts

Bruker BioSciences Corporation
Michael Willett, 978-663-3660, ext. 1411
ir@bruker-biosciences.com

Contacts

Bruker BioSciences Corporation
Michael Willett, 978-663-3660, ext. 1411
ir@bruker-biosciences.com